Depot‐medroxyprogesterone acetate (dmpa) and risk of edometrial cancer

• Main Authors: Suporn Silpisornkosol, Tieng Pardthaisong, Virote Sahapong, Choti Theetranont, Banpot Boosiri, Supawat Chutivongse, Pramuan Virutamasen, Chansuda Wongsrchanalai, Sermsri Sindhvananda, Suporn Koetsawang, Daungdao Rachawat, Amom Koetsawang, F. A. Langley, David B. Thomas Study Coordinator, Roberta M. Ray, Elizabeth A. Noonan, Janet L. Stanford, Karin A. Rosenblatt, Susan Holck, Timothy M.M. Farley, David B. Thomas
• Other Authors: Chiang Mai University
• Format: Article
• Published: 2018
• Subjects: Biochemistry, Genetics and Molecular Biology; Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/22014
• Institution: Mahidol University

This is a report of results from a case‐control study of the relationship of the long‐acting progestational contraceptive, depot‐medroxyprogesterone acetate (DMPA) to risk of endometrial carcinoma. Prior use of DMPA and information on known and suspected risk factors for endometrial cancer were asce...